Between a Rock and a Hard Place – 340B Covered Entities Sidelined as Battle Over Drug Pricing Continues
Recent conflicting court rulings from different U.S. District Courts sitting in separate federal circuits put 340B covered entities on the sidelines as the battle over the legality of policies designed to limit the scope of that program continues.…